4//SEC Filing
DRAKE PETER F 4
Accession 0000899243-19-013263
CIK 0001563880other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 5:04 PM ET
Size
9.5 KB
Accession
0000899243-19-013263
Insider Transaction Report
Form 4
DRAKE PETER F
10% Owner
Transactions
- Conversion
Series A Preferred Stock
2019-05-09−133,153→ 0 total→ Common Stock (18,881 underlying) - Conversion
Series C Preferred Stock
2019-05-09−376,023→ 0 total→ Common Stock (43,659 underlying) - Conversion
Common Stock
2019-05-09+62,540→ 62,540 total
Footnotes (2)
- [F1]On May 9, 2019, the Series A Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- [F2]On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
Documents
Issuer
Trevi Therapeutics, Inc.
CIK 0001563880
Entity typeother
Related Parties
1- filerCIK 0001267854
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 5:04 PM ET
- Size
- 9.5 KB